55
Views
5
CrossRef citations to date
0
Altmetric
Original Research

GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma

, , , , &
Pages 3731-3742 | Published online: 15 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sungsoo M. Yoo, Richard A. Cerione & Marc A. Antonyak. (2020) The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression. Small GTPases 11:2, pages 77-85.
Read now
Zitao Zhang, Polu Hu, Jin Xiong & Shoufeng Wang. (2018) Inhibiting GIT1 reduces the growth, invasion, and angiogenesis of osteosarcoma. Cancer Management and Research 10, pages 6445-6455.
Read now
Cristina Casalou, Alexandra Faustino & Duarte C. Barral. (2016) Arf proteins in cancer cell migration. Small GTPases 7:4, pages 270-282.
Read now

Articles from other publishers (2)

Runze Xu, Ran Xu, Yuanxiang Wang, Weixing Wang, Lingling Jiang & Shishun Gong. (2022) G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Tam Minh Ly, Yen-Cheng Chen, Ming-Che Lee, Chi-Tan Hu, Chuan-Chu Cheng, Hsin-Hou Chang, Ren-In You & Wen-Sheng Wu. (2021) Snail Upregulates Transcription of FN, LEF, COX2, and COL1A1 in Hepatocellular Carcinoma: A General Model Established for Snail to Transactivate Mesenchymal Genes. Cells 10:9, pages 2202.
Crossref